ResMed

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases.

CEO

Michael J. Farrell

CEOMichael J. Farrell

Employees

10,600

Employees10,600

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1989

Founded1989

Employees

10,600

Employees10,600

RMD Key Statistics

Market cap

33.15B

Market cap33.15B

Price-Earnings ratio

22.80

Price-Earnings ratio22.80

Dividend yield

1.01%

Dividend yield1.01%

Average volume

1.03M

Average volume1.03M

High today

$228.38

High today$228.38

Low today

$225.16

Low today$225.16

Open price

$227.84

Open price$227.84

Volume

219.93K

Volume219.93K

52 Week high

$293.81

52 Week high$293.81

52 Week low

$201.90

52 Week low$201.90

Stock Snapshot

As of today, ResMed(RMD) shares are valued at $227.58. The company's market cap stands at 33.15B, with a P/E ratio of 22.80 and a dividend yield of 1.0%.

During the trading session on 2026-04-09, ResMed(RMD) shares reached a daily high of $228.38 and a low of $225.16. At a current price of $227.58, the stock is +1.1% higher than the low and still -0.4% under the high.

Trading volume for ResMed(RMD) stock has reached 219.93K, versus its average volume of 1.03M.

The stock's 52-week range extends from a low of $201.90 to a high of $293.81.

RMD News

TipRanks 5h

ResMed price target lowered to $340 from $345 at Citi

Citi lowered the firm’s price target on ResMed (RMD) to $340 from $345 and keeps a Buy rating on the shares. Unlock hedge fund-level data and powerful investin...

Simply Wall St 21h

ResMed Insider Selling Raises Questions On Management Conviction And Valuation

ResMed (NYSE:RMD) has seen continued insider selling by a key executive, with no insider purchases reported over the past year. The pattern of selling without...

TipRanks 2d

ResMed CEO Michael Farrell Plans Additional Insider Sale Under Rule 144

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

69%

of 29 ratings

Buy

69%

Hold

27.6%

Sell

3.4%

More RMD News

TipRanks 3d

ResMed Adjusts CDI and Share Balances Amid Transfers, Equity Issuance and Buybacks

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.